封面
市場調查報告書
商品編碼
1797152

生物製劑市場 - 全球產業規模、佔有率、趨勢、機會和預測,按產品(植物、微生物、其他)、按應用(水果和蔬菜、穀物和穀類、其他)、按地區和競爭細分,2020-2030 年預測

Biorationals Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Botanical, Microbial, Others), By Application (Fruits & Vegetables, Grains & Cereals, Others), By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年,生物農藥市場價值為14.9億美元,預計到2030年將達到24.6億美元,複合年成長率為8.75%。全球生物農藥市場正在經歷快速轉型,從一個專業化的利基市場發展成為作物保護產業中一個具有戰略意義的重要領域。這項轉變的驅動力在於,在應對農藥抗藥性、環境惡化和食品安全法規日益嚴格的關鍵挑戰的壓力日益增大的同時,對永續、無殘留農業投入品的需求也在不斷成長。

市場概覽
預測期 2026-2030
2024年市場規模 14.9億美元
2030年市場規模 24.6億美元
2025-2030 年複合年成長率 8.75%
成長最快的領域 植物
最大的市場 亞太

生物合理性產品(包括生物農藥、微生物製劑、植物製劑、昆蟲生長調節劑和植物健康促進劑)因其精準的靶向作用、合規優勢和良好的環境特性而日益受到重視。其低毒性和生物分解性使其非常適合融入有機農業和病蟲害綜合治理 (IPM) 方案,尤其適用於水果、蔬菜和出口導向農產品等高價值作物領域。

隨著主要市場的監管機構逐步淘汰危險化學品投入,以及全球農業企業轉向更綠色的解決方案,生物合理性正成為前瞻性作物生產策略的重要工具。它們的應用不再局限於有機農場;相反,它們正被納入到傳統的農業經營中,以提升永續資格並滿足市場准入要求。

關鍵市場促進因素

有機和特色作物種植快速成長

主要市場挑戰

農民意識和技術知識有限

主要市場趨勢

數位農業與生物合理應用的融合

這一趨勢顯著提高了產品性能、農民信任和投資回報率,使生物合理性更具可擴展性,更適合大規模商業農業。

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:生物合理性市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品(植物、微生物、其他)
    • 依用途(水果和蔬菜、穀物和穀類、其他)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第6章:北美生物製藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲生物製藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章:亞太生物製品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美洲生物製品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東和非洲生物製藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章:全球生物合理性市場:SWOT 分析

第 14 章:競爭格局

  • BASF SE
  • Bayer Cropscience AG
  • Valent Biosciences Corporation
  • Certis LLC
  • UPL Limited
  • Koppert BV
  • Isagro SPA
  • Gowan Company LLC.
  • Summit Chemicals Company
  • The Wonderful Company LLC.

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16693

The Biorationals market was valued at USD 1.49 Billion in 2024 and is expected to reach USD 2.46 Billion by 2030 with a CAGR of 8.75%. The global biorationals market is undergoing a rapid transformation, evolving from a specialized niche into a strategically vital segment of the crop protection industry. This shift is being driven by the escalating need for sustainable, residue-free agricultural inputs amid mounting pressure to address critical challenges such as pesticide resistance, environmental degradation, and tightening food safety regulations.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.49 Billion
Market Size 2030USD 2.46 Billion
CAGR 2025-20308.75%
Fastest Growing SegmentBotanical
Largest MarketAsia-Pacific

Biorationals which include biopesticides, microbials, botanicals, insect growth regulators, and plant health enhancers are gaining prominence due to their precision-targeted action, regulatory compliance advantages, and favorable environmental profiles. Their low toxicity and biodegradability make them highly suitable for integration into organic farming and IPM (Integrated Pest Management) programs, particularly in high-value crop segments such as fruits, vegetables, and export-oriented produce.

As regulatory bodies across key markets phase out hazardous chemical inputs, and global agribusinesses pivot toward greener solutions, biorationals are becoming essential tools in forward-looking crop production strategies. Their adoption is no longer limited to organic farms; instead, they are now being incorporated into conventional operations seeking to enhance sustainability credentials and meet market access requirements.

Key Market Drivers

Rapid Growth of Organic and Specialty Crop Farming

The rapid growth of organic and specialty crop farming is a powerful catalyst driving the expansion of the global biorationals market. As the agricultural sector undergoes a paradigm shift toward more sustainable and value-driven practices, organic and high-value specialty crops are increasingly adopting biorational solutions to meet both agronomic and regulatory demands. This trend not only fuels demand but also reshapes product innovation, distribution strategies, and long-term market potential. Organic farming systems prohibit the use of synthetic pesticides and fertilizers, placing a strong emphasis on natural and environmentally friendly crop protection products. Biorationals including biopesticides, botanicals, microbials, and plant growth regulators are often certified for organic use and meet the strict criteria of organic certification bodies such as: USDA Organic (United States), EU Organic Certification (Europe), NPOP (India), IFOAM and JAS standards (global). As the organic farming industry expands, these certified biorationals become indispensable for maintaining crop health while staying compliant with organic protocols, thereby driving consistent demand.

Rising health consciousness, In 2023, the United States reported the highest gross adjusted household disposable income per capita among all OECD member nations, reflecting its strong consumer purchasing power. With an average disposable income of $62,722 per person, the U.S. led globally in personal income levels, highlighting the country's robust economic environment and elevated standard of living relative to other developed economies. This trend is especially pronounced in developed markets such as North America and Europe, but is rapidly gaining momentum in Asia Pacific, Latin America, and the Middle East. As retailers and exporters strive to offer clean-label, chemical-residue-free produce, farmers are under pressure to eliminate synthetic inputs. Biorationals offer the ideal solution, enabling growers to protect yields without compromising on food safety or certification standards. This increasing consumer-to-farm pull effect significantly amplifies the demand for biorational products.

Specialty crops such as fruits, vegetables, herbs, spices, tea, coffee, and floriculture products have high market value and low tolerance for pesticide residues. These crops are often grown under intensive conditions and are more vulnerable to pest and disease pressures. Even minimal contamination can lead to market rejections or price penalties, especially in export-driven economies. As a result, growers are more willing to invest in safer, residue-free protection solutions like biorationals to safeguard both quality and compliance. The high return on investment (ROI) for specialty crops reinforces the commercial attractiveness of adopting premium crop protection inputs. Many countries such as India, Mexico, Turkey, Kenya, and Vietnam are heavily reliant on the export of organic and specialty crops. These markets are governed by strict international regulations on Maximum Residue Limits (MRLs), particularly in regions such as the European Union, Japan, and the United States. Biorationals, due to their rapid degradation, non-toxic profiles, and low residue levels, help exporters meet stringent phytosanitary and safety requirements. This positions biorationals as essential tools not just for yield protection, but also for market access and compliance assurance. Exporters view biorationals as risk-mitigating assets in safeguarding trade relationships and maximizing export revenue.

Key Market Challenges

Limited Farmer Awareness and Technical Know-How

One of the most significant challenges hindering the widespread adoption of biorationals is the low level of awareness and understanding among farmers, particularly in emerging economies. Unlike conventional agrochemicals, biorational products often require a different approach in terms of application timing, dosage, and pest monitoring.

Lack of training and extension services results in improper use or underutilization, leading to inconsistent performance and reduced confidence among end users. Many small and medium-scale farmers are not familiar with integrated pest management (IPM) strategies where biorationals are most effective, making them reluctant to switch from familiar chemical pesticides. The absence of structured education programs, demonstration plots, and hands-on training further restricts product adoption, especially in rural areas. This knowledge gap slows market growth despite increasing availability of products.

Key Market Trends

Convergence of Digital Agriculture with Biorational Applications

A key trend driving future growth is the integration of digital technologies with biorational product usage, enhancing precision, efficiency, and data-driven decision-making in modern agriculture.

Smart farming platforms, powered by AI, IoT, and satellite imagery, are increasingly being used to monitor crop health, pest patterns, and soil conditions. These tools allow for timely and targeted application of biorational inputs, optimizing effectiveness and reducing waste. Biorational manufacturers are now collaborating with Agri-tech firms to develop digital advisory tools that recommend crop-specific biological solutions, dosage rates, and application schedules. Precision application technologies such as drones and autonomous sprayers are being adapted for the safe and uniform delivery of sensitive biologicals across large farms.

This trend is significantly improving product performance, farmer trust, and return on investment making biorationals more scalable and viable for large-scale commercial agriculture.

Key Market Players

  • BASF SE
  • Bayer Cropscience AG
  • Valent Biosciences Corporation
  • Certis LLC
  • UPL Limited
  • Koppert B.V.
  • Isagro S.P.A.
  • Gowan Company LLC.
  • Summit Chemicals Company
  • The Wonderful Company LLC.

Report Scope:

In this report, the Global Biorationals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biorationals Market, By Product:

  • Botanical
  • Microbial
  • Others

Biorationals Market, By Application:

  • Fruits & Vegetables
  • Grains & Cereals
  • Others

Biorationals Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biorationals Market.

Available Customizations:

Global Biorationals market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Biorationals Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Botanical, Microbial, Others)
    • 5.2.2. By Application (Fruits & Vegetables, Grains & Cereals, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Biorationals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biorationals Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Biorationals Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Biorationals Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Biorationals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biorationals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Biorationals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Biorationals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. France Biorationals Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Biorationals Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia-Pacific Biorationals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biorationals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Biorationals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Biorationals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Biorationals Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Biorationals Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. South America Biorationals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biorationals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Biorationals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Biorationals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. Middle East and Africa Biorationals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biorationals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Biorationals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Biorationals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Biorationals Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. BASF SE
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Bayer Cropscience AG
  • 14.3. Valent Biosciences Corporation
  • 14.4. Certis LLC
  • 14.5. UPL Limited
  • 14.6. Koppert B.V.
  • 14.7. Isagro S.P.A.
  • 14.8. Gowan Company LLC.
  • 14.9. Summit Chemicals Company
  • 14.10.The Wonderful Company LLC.

15. Strategic Recommendations

16. About Us & Disclaimer